Alice Wang, PharmD
On August 13, 2021, the Food and Drug Administration (FDA) expanded the Emergency Use Authorization for the Pfizer and Moderna COVID-19 vaccines to recommend a third dose for certain immunocompromised patients.1 This recommendation was based on data suggesting that these patients experienced ...